Optimal Stopping Ages for Colorectal Cancer Screening

Matthias Harlass(Erasmus MC), Reinier G.S. Meester(Erasmus MC), Jessica Chubak(Kaiser Permanente Washington Health Research Institute), Douglas A. Corley(University of California, San Francisco), Natalia Udaltsova(Kaiser Permanente), Rosita van den Puttelaar(Erasmus MC), Nicholson Collier(Argonne National Laboratory), Jonathan Ozik(Argonne National Laboratory), Ronit R. Dalmat(University of Washington), Iris Lansdorp‐Vogelaar, Christopher D. Jensen(Kaiser Permanente)

JAMA Network Open

December 19, 2024

10.1001/jamanetworkopen.2024.51715

Cited by 4

Related Papers

A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop1 1Members of the workshop composed a group of international experts in BE from gastroenterology, surgery, pathology, molecular biology, outcomes, and epidemiology. Conference chairman: Prateek Sharma; conference moderator: Kenneth McQuaid; group leaders: John Dent, M. Brian Fennerty, Richard Sampliner, Stuart Spechler; participants: Alan Cameron, Douglas Corley, Gary Falk, John Goldblum, John Hunter, Janusz Jankowski, Lars Lundell, Brian Reid, Nicholas Shaheen, Amnon Sonnenberg, Kenneth Wang, and Wilfred Weinstein.

|Gastroenterology|2004|526

Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process

|Gastroenterology|2012|378

The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial

|Gastrointestinal Endoscopy|2002|248

Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations

|Gastroenterology|2017|193

Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision

|Gastroenterology|2024|62